1. Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
   Junjie Lu et al, 2023, Frontiers in Oncology CrossRef